BigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
ParticipantS
S32
Activity from announced rounds
Activity in this selectionOct 22, 2026 · Sep 23, 2026
S32, formerly identified as Section 32, is a venture firm whose stated focus includes AI, computational biology, physical AI, infrastructure, cybersecurity and enterprise technology.
Recorded funding activity
The RoundOS history includes Basecamp’s biological models, Snorkel’s training-data systems, Ema’s enterprise agents and Network Bio’s tissue-data models. These are covered financing announcements rather than a complete portfolio.
- Rounds participated in
- 3
- Confirmed lead rounds
- 1 All roles disclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $292M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionEma
Ema builds AI Employees that automate multi-step work across enterprise HR, IT and finance systems. Businesses use its agents for processes such as recruiting, onboarding, benefits, IT support, invoice handling and payroll; the platform connects to existing applications and includes tools for configuring, governing and improving workflows.
$77MSeries B
ParticipantBasecamp Research
Basecamp Research builds biological AI models from genomic data to help design therapeutics, including protein-based medicines.
$140MSeries C
Lead